VivekKumar IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India

Dr Vivek Kumar is working as Associate Professor of Nephrology at the Postgraduate Institute of Medical Education and Research at Chandigarh in India. His research interests include epidemiology and outcomes in CKD and AKI. He is an India Alliance Clinical and Public Health Intermediate Fellow (Department of Biotechnology, Government of India and Wellcome Trust, UK). He has experience in setting up multi-centric cohort studies and clinical trials in India.

Upload Picture

https://storage.unitedwebnetwork.com/files/1099/5e15360dc5e75ca34cb2b91cf1e8adf3.jpeg

First name

Vivek

Last name

Kumar

Institution

Country

India

Friday, February 7, 2025

Time	Session

9:45 a.m. 11:15 a.m.	Hot Topics From the Tropics YN SabineKaram Chair sabinejkaram@gmail.comUnited StatesUniversity of Minnesota SourabhSharma Chair drsourabh05@gmail.comIndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India Best Abstract Winner - Basic Science: miRNA Profiling of Urinary Exosomes for Predicting Renal Outcome After Acute Kidney Injury: A Pilot Study YN-01 JaskiranKaur Oral Abstract Presenter Jaskiran265@gmail.comIndiaDepartment of Experimental Medicine and Biotechnology Best Abstract Winner - Clinical Science: Randomised Controlled Trial Comparing Rituximab to Mycophenolate Mofetil in Children and Young Adults With Steroid-Dependent Idiopathic Nephrotic Syndrome YN-02 AndreaAngeletti Oral Abstract Presenter andreaangeletti@gaslini.orgItaly Q and A YN-03 Everything You Ever Wanted to Know About Tropical Infections and the Kidney YN-04 MythriShankar Speaker mythri.nish@gmail.comIndiaInstitute of Nephrourology Challenges in the Tropics: When CKDu Becomes Less Unknown YN-05 ErangaWijewickrama Speaker erangasw@gmail.comSri LankaFaculty of Medicine, University of Colombo Roundtable Discussion YN-06 BiancaDavidson Speaker bianca.davidson@gmail.comSouth AfricaGroote Schuur Hospital, University of Cape Town ErangaWijewickrama Speaker erangasw@gmail.comSri LankaFaculty of Medicine, University of Colombo MythriShankar Speaker mythri.nish@gmail.comIndiaInstitute of Nephrourology SourabhSharma Speaker drsourabh05@gmail.comIndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India VivekKumar Speaker enigma165@yahoo.co.inIndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India Champa Hall 304
2:15 p.m. 3:45 p.m.	HIT! High Impact Clinical Trials – What and Why HIT1 Andrea Vichelli Chair andrea.viecelli@health.qld.gov.auAustraliaUniversity of Queensland VivekKumar Chair enigma165@yahoo.co.inIndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE) HIT1-1 RajivAgarwal Oral Abstract Presenter ragarwal@iu.eduUnited States Results From the REGENCY Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis HIT1-2 BradRovin Oral Abstract Presenter rovin.1@osu.eduUnited StatesThe Ohio State University Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial HIT1-3 KatherineTuttle Oral Abstract Presenter Katherine.Tuttle@providence.orgUnited StatesUniversity of Washington School of Medicine, Division of Nephrology Brahmkamal Hall - Plenary Hall

Saturday, February 8, 2025

Time	Session

9:45 a.m. 11:15 a.m.	Toward Complex Understanding of Kidney Function in AKI: Role of Biomarkers, Sex Differences and the Tropics; ISN-KSN Joint Session IK03 GirishNarayen Chair girishnarayan49@gmail.comIndiaChief of Nephrology division, udaiomni hospital, Hyderabad,India Hyeong CheonPark Chair amp97nody@gmail.comKorea (Republic of)Hyeong Cheon Park, Gangnam Severance Hospital, Yonsei University Prem PVarma Chair varmapp123@rediffmail.comIndiaPrincipal Director What Do We Know About the Association Between AKI and Long-Term Adverse Outcomes? IK03-01 Chi-yuanHsu Speaker Chi-yuan.Hsu@ucsf.eduUnited StatesUniversity of California, San Francisco Are Biomarkers in AKI Ready for Prime Time? IK03-02 ChiragParikh Speaker chirag.parikh@jhmi.eduUnited StatesJohns Hopkins University Community-acquired AKI in the Tropics - Is it a Different Disease? IK03-03 VivekKumar Speaker enigma165@yahoo.co.inIndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India Sex as a Biological Variable in the Epidemiology of AKI IK03-04 MarliesOstermann Speaker Marlies.Ostermann@gstt.nhs.ukUnited KingdomKing's College London Q&A IK03-05 Amaltas Hall B101-A

Time

Session

9:45 a.m.

11:15 a.m.

Toward Complex Understanding of Kidney Function in AKI: Role of Biomarkers, Sex Differences and the Tropics; ISN-KSN Joint Session

IK03

GirishNarayen Chair girishnarayan49@gmail.comIndiaChief of Nephrology division, udaiomni hospital, Hyderabad,India

Hyeong CheonPark Chair amp97nody@gmail.comKorea (Republic of)Hyeong Cheon Park, Gangnam Severance Hospital, Yonsei University

Prem PVarma Chair varmapp123@rediffmail.comIndiaPrincipal Director

What Do We Know About the Association Between AKI and Long-Term Adverse Outcomes?

IK03-01

Chi-yuanHsu Speaker Chi-yuan.Hsu@ucsf.eduUnited StatesUniversity of California, San Francisco
Are Biomarkers in AKI Ready for Prime Time?

IK03-02

ChiragParikh Speaker chirag.parikh@jhmi.eduUnited StatesJohns Hopkins University
Community-acquired AKI in the Tropics - Is it a Different Disease?

IK03-03

VivekKumar Speaker enigma165@yahoo.co.inIndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India
Sex as a Biological Variable in the Epidemiology of AKI

IK03-04

MarliesOstermann Speaker Marlies.Ostermann@gstt.nhs.ukUnited KingdomKing's College London
Q&A

IK03-05

Amaltas Hall B101-A